Group 1 - The unmanned retail concept declined by 1.34%, ranking among the top declines in the concept sector, with notable declines in companies like Huijin Co., Shanjike Technology, and Shen Si Electronics [1][2] - Among the unmanned retail sector, 24 stocks experienced net outflows of main funds totaling 319 million yuan, with Huijin Co. leading the outflow at 168 million yuan [2][3] - The top gainers in the unmanned retail sector included Gongxiao Daji, Xinbeiyang, and Hongqi Lianchuan, with increases of 2.59%, 1.92%, and 1.28% respectively [1][2] Group 2 - The main funds saw a net inflow in stocks like Gongxiao Daji and Xin Kaipu, with inflows of 126 million yuan and 16.43 million yuan respectively [2][3] - The top stocks with significant net outflows included Huijin Co. (-17.70%), Kela Software (-2.48%), and Newland (-0.15%) [2][3] - The overall market sentiment reflected a mixed performance across various concept sectors, with silicon energy leading gains at 3.39% while the unmanned retail sector faced notable declines [2]

Group 1 - *ST San Sheng (002742.SZ): The controlling shareholder Pan Xianwen's 32.2 million shares have been transferred, accounting for 7.30% of the total share capital, reducing his holding from 17.26% to 16.75, with no change in company control [1] - Aikang Co., Ltd. (300889.SZ): Shareholders Zhang Fengbin and Feng Renrong reduced their holdings by a total of 1.76 million shares, accounting for 1.06% of the total share capital, completing the reduction plan [1] - Allianz Ruishi (301042.SZ): Director Shen Lei reduced his holdings by 98,700 shares, accounting for 0.14% of the total share capital, with the reduction plan period ending [1] Group 2 - Baotong Technology (300031.SZ): Controlling shareholder Bao Zhifang and director Tang Yu plan to reduce their holdings by up to 8.3749 million shares and 1.526988 million shares, accounting for no more than 2% and 0.36% of the total share capital, respectively [2] - Biyiwei (688045.SH): Shareholders Fang Guang Erqi and Yuan Chengjun plan to reduce their holdings by up to 139,680 shares and 69,840 shares, accounting for no more than 2% and 1% of the total share capital, respectively [2] - Chahua Co., Ltd. (603615.SH): Shareholder Shenzhen Hanjinliang reduced 2.397 million shares, accounting for 0.99% of the total share capital, completing the reduction plan [2] Group 3 - Dacai Co., Ltd. (605287.SH): Shareholder Qingdao Dikuang Chanquan Development Co., Ltd. reduced 3.64 million shares, accounting for 2.60% of the total share capital, completing the reduction plan [3] - Dize Pharmaceutical (688192.SH): Vice President Zhang Shiying reduced 161,550 shares, accounting for 0.0035% of the total share capital, completing the reduction plan [3] - Fuhan Micro (300613.SZ): Controlling shareholder's concerted action party plans to reduce up to 6.90208 million shares, accounting for 3% of the total share capital [3] Group 4 - Guanghuan Xinwang (300383.SZ): Directors and vice presidents plan to reduce a total of up to 720,476 shares, accounting for no more than 0.04% of the total share capital [4] - Hanyu Group (300403.SZ): Director and Vice President Wu Geming plans to reduce up to 1 million shares, accounting for 0.1658% of the total share capital [4] - Haosen Intelligent (688529.SH): Shareholders plan to reduce a total of up to 3 million shares, accounting for 1.7838% of the total share capital [4] Group 5 - Huilong New Materials (301057.SZ): Controlling shareholder's concerted action party plans to reduce up to 3.482902 million shares, accounting for 3% of the total share capital excluding repurchased shares [5] - Huitong Co., Ltd. (688219.SH): Shareholder Tong'an Fund reduced 4.667815 million shares, accounting for 0.93% of the total share capital, completing the reduction plan [5] Group 6 - Jiangsu Shentong (002438.SZ): Shareholder Huzhou Fenglin Huoshan Equity Investment Partnership reduced a total of 14.205 million shares, accounting for 2.798808% of the total share capital, completing the reduction plan [6] - Jiangtian Chemical (300927.SZ): Shareholder Jiangshan Co., Ltd. reduced 1.3265 million shares, accounting for 0.92% of the total share capital [6] - Jin Sanjiang (301059.SZ): Shareholder Guangzhou Saina reduced 104,900 shares, accounting for 0.05% of the total share capital, completing the reduction plan [6] Group 7 - Jingxue Energy (301010.SZ): Controlling shareholder's concerted action party reduced 1.08 million shares, accounting for 1% of the total share capital, completing the reduction plan [7] - Jiuwu High-Tech (300631.SZ): Vice President Wang Xiaohu and Cheng Junjun plan to reduce up to 18,900 shares and 5,000 shares, accounting for no more than 0.1511% and 0.04% of the total share capital, respectively [7] - Kanghui Pharmaceutical (603139.SH): Shareholder Shanghai Sailoxian plans to reduce up to 2.9964 million shares, accounting for 3% of the total share capital [7] Group 8 - Meino Biological (301156.SZ): Shareholder's concerted action party reduced 1.297029 million shares, accounting for 0.92% of the total share capital, completing the reduction plan [8] - Minfa Aluminum Industry (002578.SZ): Shareholder Huang Tianhuo reduced 6.6702 million shares, accounting for 0.71% of the total share capital, reducing his holding to 4.9963% [8] - Nuo Puxin (002215.SZ): Directors and senior management plan to reduce a total of up to 1.8607 million shares, accounting for no more than 0.185% of the total share capital [8] Group 9 - Entropy Technology (301330.SZ): Shareholders reduced a total of 4,693,864 shares, accounting for 1.9556% of the total share capital, completing the reduction plan [9] - Shengbang Co., Ltd. (301233.SZ): Supervisor Hu Jilin plans to reduce up to 5,650 shares, accounting for 0.0111% of the total share capital [9] - Shudao Equipment (300540.SZ): Senior management did not reduce their shares, and the reduction plan period has ended [9] Group 10 - Tongyu Communications (002792.SZ): Controlling shareholder and actual controller Shi Guiqing plans to reduce up to 15,653,487 shares, accounting for 2.9963% of the total share capital [10] Group 11 - Wuzhou Xinchun (603667.SH): Senior management plans to reduce a total of up to 22,500 shares, accounting for no more than 0.0061%, 0.0067%, and 0.0037% of the total share capital [11] - New Sharp Co., Ltd. (688257.SH): Senior management plans to reduce up to 750,000 shares, accounting for no more than 0.2971% of the total share capital [11] - New Hope (000876.SZ): Senior management reduced 225,000 shares, accounting for 0.005% of the total share capital, completing the reduction plan [11] Group 12 - Youke De (688158.SH): Shareholder Zhongyi Capital reduced 882,766 shares, accounting for 0.19% of the total share capital, completing the reduction plan [12] - Changqing Technology (001324.SZ): Shareholders reduced a total of 4,165,050 shares, accounting for 3.00% of the total share capital, completing the reduction plan [12] - Changxin Bochuang (300548.SZ): Shareholders plan to reduce up to 8.6 million shares, accounting for 2.95% of the total share capital [12] Group 13 - Zhongfu Industrial (600595.SH): Shareholder Henan Yicheng Chuangtou plans to reduce up to 40 million shares, accounting for 1% of the total share capital [13] - Zhuhai Ming Technology (300232.SZ): Controlling shareholder Lin Mingfeng plans to reduce up to 21,722,009 shares, accounting for 1.99% of the total share capital [13] - Zhuoyi Information (688258.SH): Employee shareholding platform plans to reduce up to 2,271,445 shares, accounting for no more than 1.88% of the total share capital [13]

证券代码：301330 证券简称：熵基科技 公告编号：2025-066 熵基科技股份有限公司 关于持股 5%以上股东减持计划期限届满的公告 股东深圳精英士君投资企业（有限合伙）及深圳精英和义投资企 业（有限合伙）保证向本公司提供的信息内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 熵基科技股份有限公司（以下简称"公司"或"熵基科技"）于 2025 年 3 月 17 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于持股 5%以上股东减持股 份计划预披露公告》，公司持股 5%以上的股东深圳精英士君投资企业（有限合 伙）（以下简称"精英士君"）及深圳精英和义投资企业（有限合伙）（以下简 称"精英和义"）计划自减持计划预披露公告之日起十五个交易日后的三个月内， 分别以集中竞价和/或大宗交易方式减持公司股份不超过 2,886,600 股（不超过公 司剔除回购专用账户中股份数量后总股本的 1.4873%）。本次减持计划实施前， 精英士君持有公司股份 14,038,400 股，占公司总股本的 7.1511%；精英和义持有 公 ...

证券代码：301330 证券简称：熵基科技 公告编号：2025-065 熵基科技股份有限公司 关于开立闲置募集资金现金管理专用结算账户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 为提高闲置募集资金使用效率，合理利用暂时闲置的募集资金，增加公司投 资收益和股东回报，熵基科技股份有限公司（以下简称"公司"）于 2024 年 8 月 28 日召开第三届董事会第十一次会议和第三届监事会第十次会议，审议通过 了《关于使用部分暂时闲置募集资金进行现金管理的议案》，同意公司及子公司 使用不超过人民币 80,000 万元（含本数）的部分暂时闲置募集资金（含超募资 金）进行现金管理，该使用额度及授权的有效期自公司董事会审议通过之日起 12 个月内有效，并在上述额度内滚动使用。具体内容详见公司于 2024 年 8 月 30 日 在巨潮资讯网（http://www.cninfo.com.cn）披露的《关于使用部分暂时闲置募集 资金进行现金管理的公告》（公告编号：2024-040）。 一、开立闲置募集资金现金管理专用结算账户的情况 近日，公司新开立了闲置募集资金现金管理专 ...

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant growth, driven by advancements from companies like Neuralink and recent breakthroughs in China, indicating a potential commercialization of BCI technology in the near future [2][4][5]. Group 1: Neuralink Developments - Neuralink has showcased its latest research and product development, with 7 participants currently using the device for an average of 50 hours per week, peaking over 100 hours [2]. - The company plans to implant devices in the speech cortex by the end of 2025 to decode silent speech from brain signals, and aims to increase electrode channels to 3,000 by 2026 to explore restoring vision [2][3]. - By 2028, Neuralink anticipates implanting over 25,000 electrodes to address mental health issues and explore integration with AI, potentially allowing humans to control robots directly [3]. Group 2: Market Potential and Growth - The global BCI market is projected to grow from $2.62 billion in 2024 to approximately $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17.35% [4]. - The BCI technology is recognized as one of the most disruptive technologies of the 21st century, with expectations for a surge in medical product applications over the next 5 to 10 years [4]. Group 3: Domestic Developments in China - Recent successful trials in China, including the first invasive BCI-assisted rehabilitation for a stroke patient, highlight the rapid advancement of BCI technology towards commercialization [4]. - The "Beijing Brain Institute" has developed a flexible, high-throughput, semi-invasive BCI system that has entered clinical trials, marking significant progress in the field [4]. Group 4: Industry Insights - The domestic BCI industry is benefiting from technological breakthroughs and supportive government policies, which are expected to accelerate the commercialization process [5]. - BCI products are categorized into non-invasive and invasive types, with non-invasive products leading in commercialization, while invasive products are still in clinical research stages [6]. - Despite the promising outlook, the BCI industry faces challenges related to safety, regulatory approval, and the need for foundational research [6][7].

证券代码：301330 证券简称：熵基科技 公告编号：2025-064 熵基科技股份有限公司 关于注销及开立闲置募集资金现金管理专用结算账户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 三、投资风险及风险控制措施 （一）投资风险分析 1、虽然投资产品均经过严格的评估，但金融市场受宏观经济影响，不排除 该项投资受到市场波动的影响。 为提高闲置募集资金使用效率，合理利用暂时闲置的募集资金，增加公司投 资收益和股东回报，熵基科技股份有限公司（以下简称"公司"）于 2024 年 8 月 28 日召开第三届董事会第十一次会议和第三届监事会第十次会议，审议通过 了《关于使用部分暂时闲置募集资金进行现金管理的议案》，同意公司及子公司 使用不超过人民币 80,000 万元（含本数）的部分暂时闲置募集资金（含超募资 金）进行现金管理，该使用额度及授权的有效期自公司董事会审议通过之日起 12 个月内有效，并在上述额度内滚动使用。具体内容详见公司于 2024 年 8 月 30 日 在巨潮资讯网（http://www.cninfo.com.cn）披露的《关于使用部分暂时闲置 ...

Group 1 - A total of 24 companies were investigated by institutions on June 25, with 17 companies specifically targeted by funds [1][2] - The most popular company among funds was Botao Bio, which had 21 participating funds, followed by Sanfu Outdoor and Entropy Technology with 7 and 6 funds respectively [1][2] - The companies investigated belong to 12 different industries, with the textile and apparel, and pharmaceutical and biotechnology sectors having the most companies, each with 3 stocks listed [1] Group 2 - Among the companies investigated, 3 had a total market capitalization exceeding 50 billion yuan, while 13 had a market cap below 10 billion yuan [1] - In terms of market performance, 9 stocks among the investigated companies saw an increase in the last 5 days, with Haike Xinyuan, Bai'ao Intelligent, and Ganfeng Lithium leading with increases of 50.83%, 10.42%, and 5.88% respectively [1][2] - Conversely, 8 stocks experienced declines, with Mankalon, Botao Bio, and China Merchants Energy showing the largest drops of 7.94%, 5.35%, and 4.76% respectively [1][2]

Group 1: Company Overview and Business Strategy - The company aims to enhance market competitiveness through AI technology and brand influence, targeting revenue growth aligned with high equity incentive goals [2] - Focus on optimizing product and business structure, controlling costs, and improving operational efficiency to achieve performance growth [2] Group 2: Brain-Machine Interface (BMI) Technology - The company is exploring non-invasive BMI technology, particularly in the fields of elderly care, healthcare, and education [2][4] - Utilizes multi-modal data fusion technology ("EEG + EOG + EMG") to overcome precision limitations of traditional single-modal devices [2] Group 3: Applications in Education - Launching non-invasive brain-computer interface products aimed at enhancing focus among youth through interactive games and real-time EEG signal collection [3] Group 4: Partnerships and Collaborations - Established a long-term partnership with Workday to provide payroll calculation services for various sectors, enhancing operational efficiency for clients [5] Group 5: Mergers and Acquisitions - Ongoing audit of financial indicators related to the acquisition of "Longzhiyuan," with expectations of synergistic effects in product, technology, and market resources [6] Group 6: Ralvie AI Business Model - Ralvie AI focuses on work management and operational efficiency, quantifying employee work time and efficiency as a basis for performance evaluation [7] Group 7: Mars Wisdom Solutions - Mars Wisdom leverages advanced AI technologies to address semantic understanding, visual analysis, and data retrieval challenges, integrating with existing business platforms for enhanced service delivery [8] Group 8: Investor Relations Activity - The investor relations activity did not involve any undisclosed significant information [9]

证券代码：301330 证券简称：熵基科技 公告编号：2025-062 熵基科技股份有限公司 关于持股 5%以上股东权益变动触及 1%整数倍的公告 股东深圳精英士君投资企业（有限合伙）及深圳精英和义投资企 业（有限合伙）保证向本公司提供的信息内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 熵基科技股份有限公司（以下简称"公司"或"熵基科技"）于 2025 年 3 月 17 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于持股 5%以上股东减持股 份计划预披露公告》，公司持股 5%以上的股东深圳精英士君投资企业（有限合 伙）（以下简称"精英士君"）及深圳精英和义投资企业（有限合伙）（以下简 称"精英和义"）计划自减持计划预披露公告之日起十五个交易日后的三个月内， 分别以集中竞价和/或大宗交易方式减持公司股份不超过 2,886,600 股（不超过公 司剔除回购专用账户中股份数量后总股本的 1.4873%）。本次减持计划实施前， 精英士君持有公司股份 14,038,400 股，占公司总股本的 7.1511%；精英和义 ...

证券代码：301330 证券简称：熵基科技 公告编号：2025-063 熵基科技股份有限公司（以下简称"公司"）于 2025 年 4 月 21 日召开第三 届董事会第十七次会议、2025 年 5 月 15 日召开 2024 年年度股东大会，审议通 过了《关于变更注册资本及修改〈公司章程〉并办理工商登记变更手续的议案》， 具体内容详见公司于 2025 年 4 月 23 日在巨潮资讯网（http://www.cninfo.com.cn） 披露的《关于变更注册资本及修改〈公司章程〉并办理工商登记变更手续的公告》 （公告编号：2025-048）。 近日，公司完成了工商变更登记及修订后的《公司章程》备案，取得了东莞 市市场监督管理局核发的《营业执照》。现将相关情况公告如下： 一、公司注册资本变更相关情况 公司于 2025 年 6 月 4 日实施完成 2024 年年度权益分派方案，本次实施的权 益分派方案为：以截至 2025 年 6 月 3 日公司总股本 196,312,325 股扣除公司回购 专户中已回购股份 1,116,200 股后的股本 195,196,125 股为基数，向全体股东每 10 股转增 2 股。本次权益 ...